HOOK(Delisted)
HOOKIPA Pharma (HOOK) Stock Statistics, Valuation & Financial Metrics
Total Valuation
HOOKIPA Pharma market cap is -- and enterprise value is --.
Share Statistics
HOOKIPA Pharma has 12.20M shares outstanding, with a free float of 6.85M.
Valuation Ratios
HOOKIPA Pharma's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
HOOKIPA Pharma debt-to-equity ratio is -- and debt-to-assets ratio is 0.44.
Liquidity
HOOKIPA Pharma's current ratio is 3.61, quick ratio is 3.61, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
HOOKIPA Pharma's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
HOOKIPA Pharma gross margin is 100.00%, operating margin is -860.18%, and net margin is -784.01%.
Cost Structure
HOOKIPA Pharma spends 654.45% of revenue on R&D and 246.56% on SG&A.
Operating Efficiency
HOOKIPA Pharma's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
HOOKIPA Pharma's revenue is 9.35M, gross profit is 9.35M, net income is --, and EBITDA is --.
Balance Sheet
HOOKIPA Pharma's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
HOOKIPA Pharma's operating cash flow is -52.77M, free cash flow is -52.87M, and CapEx is -98.00K.
Dividends & Yields
HOOKIPA Pharma dividend yield is --, with a payout ratio of 0.00% and dividend per share of --.
Analyst Rating
HOOKIPA Pharma's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A company that develops a new class of immunotherapies based on its proprietary arenavirus platform
Per Share Metrics
HOOKIPA Pharma's EPS is --, book value per share is --, and free cash flow per share is --.
